Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.5K Hold
275
﹤0.01% 185
2026
Q1
$17.3K Hold
275
﹤0.01% 189
2025
Q4
$18.3K Hold
275
0.01% 184
2025
Q3
$18.5K Hold
275
0.01% 176
2025
Q2
$24K Hold
275
0.01% 160
2025
Q1
$18.8K Buy
+275
New +$22.4K 0.01% 170

Other funds holding DXCM

SRH Advisors's DXCM Position: Q2 2026 in Review

SRH Advisors held its DexCom (DXCM) position steady in Q2 2026 at 275 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #185.

SRH Advisors first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $24K in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • SRH Advisors held 275 shares of DexCom worth $18.5K as of Q2 2026.
  • SRH Advisors left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of SRH Advisors's portfolio in Q2 2026, its #185 holding.
  • SRH Advisors first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • SRH Advisors's DexCom position peaked at $24K in Q2 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on SRH Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.